[HCO3-]
pH
|
Approximate [H+]
(mmol/L)
|
7.00
|
100
|
7.05
|
89
|
7.10
|
79
|
7.15
|
71
|
7.20
|
63
|
7.25
|
56
|
7.30
|
50
|
7.35
|
45
|
7.40
|
40
|
7.45
|
35
|
7.50
|
32
|
7.55
|
28
|
7.60
|
25
|
7.65
|
22
|
pH > 7.45 alkalemia
- This is usually the primary disorder
- Remember: an acidosis or alkalosis may be present even if the pH is in the normal range (7.35 – 7.45)
- You will need to check the PaCO2, HCO3- and anion gap.
Acidosis
|
Respiratory
|
pH ↓
|
PaCO2 ↑
|
Acidosis
|
Metabolic&
|
pH ↓
|
PaCO2 ↓
|
Alkalosis
|
Respiratory
|
pH ↑
|
PaCO2 ↓
|
Alkalosis
|
Metabolic
|
pH ↑
|
PaCO2 ↑
|
Disorder
|
Expected compensation
|
Correction factor
|
Metabolic acidosis
|
PaCO2 = (1.5 x [HCO3-]) +8
|
± 2
|
Acute respiratory acidosis
|
Increase in [HCO3-]= ∆ PaCO2/10
|
± 3
|
Chronic respiratory acidosis (3-5 days)
|
Increase in [HCO3-]= 3.5(∆ PaCO2/10)
|
|
Metabolic alkalosis
|
Increase in PaCO2 = 40 + 0.6(∆HCO3-)
|
|
Acute respiratory alkalosis
|
Decrease in [HCO3-]= 2(∆ PaCO2/10)
|
|
Chronic respiratory alkalosis
|
Decrease in [HCO3-] = 5(∆ PaCO2/10) to 7(∆ PaCO2/10)
|
- A normal anion gap is approximately 12 meq/L.
- In patients with hypoalbuminemia, the normal anion gap is lower than 12 meq/L; the “normal” anion gap in patients with hypoalbuminemia is about 2.5 meq/L lower for each 1 gm/dL decrease in the plasma albumin concentration (for example, a patient with a plasma albumin of 2.0 gm/dL would be approximately 7 meq/L.)
- If the anion gap is elevated, consider calculating the osmolal gap in compatible clinical situations.
- Elevation in AG is not explained by an obvious case (DKA, lactic acidosis, renal failure
- Toxic ingestion is suspected
- OSM gap = measured OSM – (2[Na+] – glucose/18 – BUN/2.8
- The OSM gap should be < 10
- If ∆AG/∆[HCO3-] < 1.0, then a concurrent non-anion gap metabolic acidosis is likely to be present.
- If ∆AG/∆[HCO3-] > 2.0, then a concurrent metabolic alkalosis is likely to be present.
Disorder
|
pH
|
Primary problem
|
Compensation
|
Metabolic acidosis
|
↓
|
↓ in HCO3-
|
↓ in PaCO2
|
Metabolic alkalosis
|
↑
|
↑ in HCO3-
|
↑ in PaCO2
|
Respiratory acidosis
|
↓
|
↑ in PaCO2
|
↑ in [HCO3-]
|
Respiratory alkalosis
|
↑
|
↓ in PaCO2
|
↓ in [HCO3-]
|
- Airway obstruction
– Upper
– Lower- COPD
- asthma
- other obstructive lung disease
- CNS depression
- Sleep disordered breathing (OSA or OHS)
- Neuromuscular impairment
- Ventilatory restriction
- Increased CO2 production: shivering, rigors, seizures, malignant hyperthermia, hypermetabolism, increased intake of carbohydrates
- Incorrect mechanical ventilation settings
- CNS stimulation: fever, pain, fear, anxiety, CVA, cerebral edema, brain trauma, brain tumor, CNS infection
- Hypoxemia or hypoxia: lung disease, profound anemia, low FiO2
- Stimulation of chest receptors: pulmonary edema, pleural effusion, pneumonia, pneumothorax, pulmonary embolus
- Drugs, hormones: salicylates, catecholamines, medroxyprogesterone, progestins
- Pregnancy, liver disease, sepsis, hyperthyroidism
- Incorrect mechanical ventilation settings
- Hypovolemia with Cl- depletion
- GI loss of H+
- Vomiting, gastric suction, villous adenoma, diarrhea with chloride-rich fluid
- Renal loss H+
- Loop and thiazide diuretics, post-hypercapnia (especially after institution of mechanical ventilation)
- GI loss of H+
- Hypervolemia, Cl- expansion
- Renal loss of H+: edematous states (heart failure, cirrhosis, nephrotic syndrome), hyperaldosteronism, hypercortisolism, excess ACTH, exogenous steroids, hyperreninemia, severe hypokalemia, renal artery stenosis, bicarbonate administration
- Elevated anion gap:
- Methanol intoxication
- Uremia
- Diabetic ketoacidosisa, alcoholic ketoacidosis, starvation ketoacidosis
- Paraldehyde toxicity
- Isoniazid
- Lactic acidosisa
- Type A: tissue ischemia
- Type B: Altered cellular metabolism
- Ethanolb or ethylene glycolb intoxication
- Salicylate intoxication
b Frequently associated with an osmolal gap
- Normal anion gap: will have increase in [Cl-]
- GI loss of HCO3-
- Diarrhea, ileostomy, proximal colostomy, ureteral diversion
- Renal loss of HCO3-
- proximal RTA
- carbonic anhydrase inhibitor (acetazolamide)
- Renal tubular disease
- ATN
- Chronic renal disease
- Distal RTA
- Aldosterone inhibitors or absence
- NaCl infusion, TPN, NH4+ administration
- GI loss of HCO3-
Disorder
|
Characteristics
|
Selected situations
|
Respiratory acidosis with metabolic acidosis
|
↓in pH
↓ in HCO3 ↑ in PaCO2 |
|
Respiratory alkalosis with metabolic alkalosis
|
↑in pH
↑ in HCO3- ↓ in PaCO2 |
|
Respiratory acidosis with metabolic alkalosis
|
pH in normal range
↑ in PaCO2, ↑ in HCO3- |
|
Respiratory alkalosis with metabolic acidosis
|
pH in normal range
↓ in PaCO2 ↓ in HCO3 |
|
Metabolic acidosis with metabolic alkalosis
|
pH in normal range
HCO3- normal |
|
- Rose, B.D. and T.W. Post. Clinical physiology of acid-base and electrolyte disorders, 5th ed. New York: McGraw Hill Medical Publishing Division, c2001.
- Fidkowski, C And J. Helstrom. Diagnosing metabolic acidosis in the critically ill: bridging the anion gap, Stewart and base excess methods. Can J Anesth 2009;56:247-256.
- Adrogué, H.J. and N.E. Madias. Management of life-threatening acid-base disorders—first of two parts. N Engl J Med1998;338:26-34.
- Adrogué, H.J. and N.E. Madias. Management of life-threatening acid-base disorders—second of two parts. N Engl J Med1998;338:107-111.
Leave a Reply
You must be logged in to post a comment.